{
    "msg": "获取章节试题成功",
    "data": {
        "test": {
            "ReturnMessage": "取数据成功",
            "APPEName": "ZY_LCZY_YTMJ",
            "GenDate": "Wed May 15 2019 02:27:18 GMT+0800 (CST)",
            "StyleItems": [
                {
                    "StyleID": 1,
                    "Style": "A1型题",
                    "Explain": "A1型题：每一道考试题下面有A、B、C、D、E五个备选答案。请从中选择一个最佳答案。",
                    "Score": 1,
                    "Type": "ATEST",
                    "SubType": "",
                    "TestCount": 12,
                    "TestItems": [
                        {
                            "Title": "d2f28a47c06e4777802f5d9d55208fadd68431785e84b3c0c553110a6e40fe2fe6b44e31fbbace9b",
                            "Explain": "人工主动免疫（artificialactiveimmunization）是用疫苗接种人体，使之产生特异性免疫，从而预防传染病发生的措施。疫苗（vaccine）是病原微生物或其代谢产物经物理化学因素处理后，使之失去毒性但保留抗原性所制备的生物制品。包括灭活疫苗、减毒活疫苗、类毒素、重组疫苗、DNA疫苗。",
                            "TestPoint": "免疫学防治",
                            "Answer": "B",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "Content": "给机体注射抗毒素",
                                    "ItemName": "A"
                                },
                                {
                                    "Content": "给机体注射类毒素",
                                    "ItemName": "B"
                                },
                                {
                                    "Content": "给机体注射丙种球蛋白",
                                    "ItemName": "C"
                                },
                                {
                                    "Content": "给机体注射细胞因子",
                                    "ItemName": "D"
                                },
                                {
                                    "Content": "给机体注射胎盘球蛋白",
                                    "ItemName": "E"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002475,
                            "ATestID": 43002475,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 475,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "d2f28a47c06e4777802f5d9d55208fad993690970097b1a748346db707306c6f55d5944d91e813b7",
                            "Explain": "人工被动免疫就是采用人工方法向机体输入由他人或动物产生的免疫效应物，如免疫血清、淋巴因子等，使机体立即获得免疫力，达到防治某种疾病的目的。注射免疫球蛋白。",
                            "TestPoint": "免疫学防治",
                            "Answer": "D",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "Content": "注射菌苗",
                                    "ItemName": "A"
                                },
                                {
                                    "Content": "口服麻痹糖丸",
                                    "ItemName": "B"
                                },
                                {
                                    "Content": "接种BCG",
                                    "ItemName": "C"
                                },
                                {
                                    "Content": "注射免疫球蛋白",
                                    "ItemName": "D"
                                },
                                {
                                    "Content": "注射类毒素",
                                    "ItemName": "E"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002476,
                            "ATestID": 43002476,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 475,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "002235026aa4a9226ae0adb1972ef2603703af6a0cad1d6cb86d02b02b237be7",
                            "Explain": "人免疫球蛋白俗称人丙种球蛋白，是从上千份血浆中提取的一种生物制剂，其主要成分是免疫球蛋白IgG抗体。主要功能是与抗原起免疫反应，从而阻断抗原（比如病毒产生抗原）对人体的危害。",
                            "TestPoint": "免疫学防治",
                            "Answer": "D",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "亚单位疫苗"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "基因工程疫苗"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "合成肽疫苗"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "人免疫球蛋白制剂"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "DNA疫苗"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002477,
                            "ATestID": 43002477,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 475,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "002235026aa4a922796d4a9749696c24e7a681b9313f028f19236595d438ed488100456bc7b3a55f",
                            "Explain": "母体的特异性抗体通过胎盘或初乳进入胎儿体内或婴儿体内，使胎儿或婴儿被动的获得母体抗体的方式。",
                            "TestPoint": "免疫学防治",
                            "Answer": "C",
                            "Difficulty": "易",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "注射丙种球蛋白"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "注射抗毒素血清"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "经胎盘从母体得到的抗体"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "接种类毒素产生的抗体"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "接种疫苗产生的抗体"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002478,
                            "ATestID": 43002478,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 475,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "002235026aa4a9225a0ef8488a8b2a46eb367740632388e2ab1b2be255fae49c",
                            "Explain": "主要作用是诱导具有免疫力的特异抗体的产生．为了维持血清中抗体的水平，常需多次接种．注射的局部和全身的反应也较重、比如霍乱、百日咳、伤寒、狂犬病等疫苗。",
                            "TestPoint": "免疫学防治",
                            "Answer": "E",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "BCG"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "小儿麻痹糖丸"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "麻疹疫苗"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "鼠疫疫苗"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "伤寒疫苗"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002479,
                            "ATestID": 43002479,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 475,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "002235026aa4a9228d372e7364ffe305067c53ef245f39d6f8ac0e3e48aa1d87",
                            "Explain": "人工主动免疫是用疫苗接种人体，使之产生特异性免疫，从而预防传染病发生的措施。",
                            "TestPoint": "免疫学防治",
                            "Answer": "B",
                            "Difficulty": "易",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "隐性感染——自然被动免疫"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "接种疫苗——人工主动免疫"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "接种类毒素——人工被动免疫"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "注射抗毒素——人工主动免疫"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "从初乳中获得SIgA-人工被动免疫"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002480,
                            "ATestID": 43002480,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 475,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "bfe7149fb3a9c102d256a15a0f7b094a5192b825e71fdb54152979fa585c13b5e42519cbd24c5bd6b412a3a99aedc39ebffe62ddba2a9865758d4584d9a69cb1",
                            "Explain": "观察7天。对没有接受白喉类毒素全程免疫的幼儿，最好给予白喉类抗毒素时注射。",
                            "TestPoint": "免疫学防治",
                            "Answer": "C",
                            "Difficulty": "易",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "白喉类毒素"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "BCG"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "白喉抗毒素"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "丙种球蛋白"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "胎盘球蛋白"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002481,
                            "ATestID": 43002481,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 475,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "002235026aa4a922f85b99428b6caace2323d5474ba48bb5a45eb1268d4e54e1",
                            "Explain": "目前已经在临床使用的减毒活疫苗有：麻疹减毒活疫苗、甲型肝炎减毒活疫苗、冻干甲肝减毒活疫苗、冻干水痘减毒活疫苗、乙型脑炎减毒活疫苗、风疹减毒活疫苗、腮腺炎减毒活疫苗、口服脊髓灰质炎减毒活疫苗、口服狂犬病减毒活疫苗、鼠疫疫苗等。",
                            "TestPoint": "免疫学防治",
                            "Answer": "A",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "Content": "鼠疫菌苗",
                                    "ItemName": "A"
                                },
                                {
                                    "Content": "伤寒菌苗",
                                    "ItemName": "B"
                                },
                                {
                                    "Content": "百日咳菌苗",
                                    "ItemName": "C"
                                },
                                {
                                    "Content": "类毒素",
                                    "ItemName": "D"
                                },
                                {
                                    "Content": "森林脑炎疫苗",
                                    "ItemName": "E"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002482,
                            "ATestID": 43002482,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 475,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "1262d46e5de175296bd8b4b8c38f4e85a941e062227fd2607b72c76b23631a5f49832971207f9bd2593ac939632a6197c774002a09f4108d69e663ff316a2124d7a4adadfcc560da",
                            "Explain": "可作为治疗非霍奇金淋巴瘤的单克隆抗体的靶分子是CD20。",
                            "TestPoint": "非霍奇金淋巴瘤",
                            "Answer": "D",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "CD3"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "CD4"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "CD8"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "CD20"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "CD21"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43015085,
                            "ATestID": 43015085,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 475,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "966b1f4dabde7a36353a343ec29a905774f0cd1973aa0262e543b9fdfef91b54",
                            "Explain": "治疗多发性硬化症可用β干扰素。",
                            "TestPoint": "多发性硬化症",
                            "Answer": "C",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "抗CD3单克隆抗体"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "抗肿瘤坏死因子抗体"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "β干扰素"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "α干扰素"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "EPO"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43015087,
                            "ATestID": 43015087,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 475,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "1b55faf0f3062747944774f884578776728fb82421a7341b",
                            "Explain": "治疗贫血可用EPO。",
                            "TestPoint": "贫血",
                            "Answer": "E",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "抗CD3单克隆抗体"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "抗肿瘤坏死因子抗体"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "β干扰素"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "α干扰素"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "EPO"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43015088,
                            "ATestID": 43015088,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 475,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "6463fa905dbc9f2d2a05d00a92fee8612b14a38f729a15de49219c53c788a07d",
                            "Explain": "治疗类风湿关节炎可用抗肿瘤坏死因子抗体。",
                            "TestPoint": "类风湿关节炎",
                            "Answer": "B",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "抗CD3单克隆抗体"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "抗肿瘤坏死因子抗体"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "β干扰素"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "α干扰素"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "EPO"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43015089,
                            "ATestID": 43015089,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 475,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        }
                    ]
                },
                {
                    "StyleID": 3,
                    "Style": "B1型题",
                    "Explain": "B1型题：以下提供若干组考题，每组考题共用在考题前列出的A、B、C、D、E五个备选答案。请从中选择一个与问题关系最密切的答案。某个备选答案可能被选择一次、多次或不被选择。",
                    "Score": 1,
                    "Type": "BTEST",
                    "SubType": "单项",
                    "TestCount": 7,
                    "TestItems": [
                        {
                            "Title": "332098cd6ac4bea844e8c794dac419c7671df1722d9c03f62d206d26c0481951e23d460a4b1dbda4b05202687ae0e8e5",
                            "Explain": "用自体LAK、TIL细胞治疗恶性肿瘤为过继免疫治疗，过继免疫是把致敏淋巴细胞（具有特异免疫力的）或致敏淋巴细胞的产物（例如转移因子和免疫核糖核酸等）输给细胞免疫功能低下者（如肿瘤病人），使其获得抗肿瘤免疫力。",
                            "TestPoint": "免疫系统",
                            "Answer": "D",
                            "Difficulty": "难",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "应用生物应答调节剂进行免疫治疗"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "应用细胞因子拮抗剂的治疗"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "应用细胞因子的治疗"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "过继免疫治疗"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "应用抗体进行免疫治疗"
                                }
                            ],
                            "AllTestID": 43002483,
                            "BTestID": 43000618,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 475,
                            "BTestItems": [
                                {
                                    "BTestItemID": 43000618,
                                    "Title": "332098cd6ac4bea844e8c794dac419c7671df1722d9c03f62d206d26c0481951e23d460a4b1dbda4b05202687ae0e8e5",
                                    "Explain": "用自体LAK、TIL细胞治疗恶性肿瘤为过继免疫治疗，过继免疫是把致敏淋巴细胞（具有特异免疫力的）或致敏淋巴细胞的产物（例如转移因子和免疫核糖核酸等）输给细胞免疫功能低下者（如肿瘤病人），使其获得抗肿瘤免疫力。",
                                    "TestPoint": "免疫系统",
                                    "Answer": "D",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43000619,
                                    "Title": "f1fd6de5185dc3f20b2abb11a4d0d00e24c6e5d06a7289a00c03140a1dc160d853f0bd5cb885b45f486083a71a3126ec",
                                    "Explain": "用抗TNF单抗治疗类风湿关节炎为应用细胞因子拮抗剂的治疗。",
                                    "TestPoint": "免疫系统",
                                    "Answer": "B",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43000620,
                                    "Title": "95a110ff5beb6ee293bb019f1b572c33e9f3dc941cf3f12db29a0373da7603660f29a03254d84346",
                                    "Explain": "用卡介苗辅助治疗膀胱癌为应用生物应答调节剂进行免疫治疗。",
                                    "TestPoint": "免疫系统",
                                    "Answer": "A",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43000621,
                                    "Title": "3eac9895199111ca6626b2c0289fa98d78056aa15a14227d9026dd208d808c24b6c7f6e745137bdd3fb6d0dc361cb0923e3c25581ab8945e",
                                    "Explain": "注射破伤风抗毒素血清治疗破伤风为应用抗体进行免疫治疗。",
                                    "TestPoint": "免疫系统",
                                    "Answer": "E",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43000622,
                                    "Title": "8ffc6d88a0f7303d10891288d3b91ea5678683da7d0435d590135bd86f21a721e01b9deabd3da437",
                                    "Explain": "用IFN-α治疗毛细胞白血病应用细胞因子的治疗。",
                                    "TestPoint": "免疫系统",
                                    "Answer": "C",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        },
                        {
                            "Title": "0174600dddfc4118c1b698ababf9e813b2ac1aee67b6281ef69d52bf7e8ca8bd5d5696f9820cf1f747bb17f8da0c1bdc",
                            "Explain": "一些化学制剂具有明显的免疫刺激作用，如左旋咪唑、多聚核苷酸、西咪替丁、异丙酯骼酐等都能通过不同的方式刺激机体的免疫功能。其中左旋咪唑和西咪替丁是研究得比较多的免疫增强药物，所以选A。",
                            "TestPoint": "免疫系统",
                            "Answer": "A",
                            "Difficulty": "难",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "左旋咪唑"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "环磷酰胺"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "卡介苗"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "FK-506"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "胸腺肽"
                                }
                            ],
                            "AllTestID": 43002484,
                            "BTestID": 43000623,
                            "SrcID": 9,
                            "SbjID": 41,
                            "CptID": 475,
                            "BTestItems": [
                                {
                                    "BTestItemID": 43000623,
                                    "Title": "0174600dddfc4118c1b698ababf9e813b2ac1aee67b6281ef69d52bf7e8ca8bd5d5696f9820cf1f747bb17f8da0c1bdc",
                                    "Explain": "一些化学制剂具有明显的免疫刺激作用，如左旋咪唑、多聚核苷酸、西咪替丁、异丙酯骼酐等都能通过不同的方式刺激机体的免疫功能。其中左旋咪唑和西咪替丁是研究得比较多的免疫增强药物，所以选A。",
                                    "TestPoint": "免疫系统",
                                    "Answer": "A",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43000624,
                                    "Title": "0174600dddfc411825d1cac44ead6a23cf66c3b31a63b137e3bfd83760b70b738e950063531da9579a97b88a33b95a6d",
                                    "Explain": "微生物制剂这类免疫抑制剂的作用主要来源于微生物的代谢产物，多为抗生素或抗真菌药物，它们对T细胞有选择性抑制作用。环孢霉素A、FK-506、雷帕霉素等都属于此类制剂，选D。",
                                    "TestPoint": "免疫系统",
                                    "Answer": "D",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        }
                    ]
                }
            ]
        },
        "isVip": 0,
        "testInfo": [
            {
                "AllTestID": 43002475,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002475,
                        "ChildTableID": -1,
                        "UserCount": 822,
                        "RightCount": 488,
                        "FavCount": 19,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002475,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 43002476,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002476,
                        "ChildTableID": -1,
                        "UserCount": 754,
                        "RightCount": 587,
                        "FavCount": 15,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 2
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002476,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 2
            },
            {
                "AllTestID": 43002477,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002477,
                        "ChildTableID": -1,
                        "UserCount": 739,
                        "RightCount": 559,
                        "FavCount": 13,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002477,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43002478,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002478,
                        "ChildTableID": -1,
                        "UserCount": 707,
                        "RightCount": 610,
                        "FavCount": 8,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 5
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002478,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 5
            },
            {
                "AllTestID": 43002479,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002479,
                        "ChildTableID": -1,
                        "UserCount": 840,
                        "RightCount": 335,
                        "FavCount": 30,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 6
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002479,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 6
            },
            {
                "AllTestID": 43002480,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002480,
                        "ChildTableID": -1,
                        "UserCount": 729,
                        "RightCount": 476,
                        "FavCount": 8,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002480,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43002481,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002481,
                        "ChildTableID": -1,
                        "UserCount": 722,
                        "RightCount": 463,
                        "FavCount": 13,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002481,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43002482,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002482,
                        "ChildTableID": -1,
                        "UserCount": 750,
                        "RightCount": 340,
                        "FavCount": 18,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 2
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002482,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 2
            },
            {
                "AllTestID": 43015085,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015085,
                        "ChildTableID": -1,
                        "UserCount": 667,
                        "RightCount": 412,
                        "FavCount": 25,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 5
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015085,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 5
            },
            {
                "AllTestID": 43015087,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015087,
                        "ChildTableID": -1,
                        "UserCount": 671,
                        "RightCount": 366,
                        "FavCount": 20,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 6
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015087,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 6
            },
            {
                "AllTestID": 43015088,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015088,
                        "ChildTableID": -1,
                        "UserCount": 602,
                        "RightCount": 511,
                        "FavCount": 5,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015088,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43015089,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015089,
                        "ChildTableID": -1,
                        "UserCount": 646,
                        "RightCount": 409,
                        "FavCount": 16,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 5
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015089,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 5
            },
            {
                "AllTestID": 43002483,
                "ChildTableID": 43000618,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002483,
                        "ChildTableID": 43000618,
                        "UserCount": 760,
                        "RightCount": 327,
                        "FavCount": 22,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 2
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002483,
                    "ChildTableID": 43000618
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 2
            },
            {
                "AllTestID": 43002483,
                "ChildTableID": 43000619,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002483,
                        "ChildTableID": 43000619,
                        "UserCount": 755,
                        "RightCount": 351,
                        "FavCount": 21,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002483,
                    "ChildTableID": 43000619
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43002483,
                "ChildTableID": 43000620,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002483,
                        "ChildTableID": 43000620,
                        "UserCount": 729,
                        "RightCount": 469,
                        "FavCount": 16,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 6
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002483,
                    "ChildTableID": 43000620
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 6
            },
            {
                "AllTestID": 43002483,
                "ChildTableID": 43000621,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002483,
                        "ChildTableID": 43000621,
                        "UserCount": 717,
                        "RightCount": 510,
                        "FavCount": 7,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002483,
                    "ChildTableID": 43000621
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43002483,
                "ChildTableID": 43000622,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002483,
                        "ChildTableID": 43000622,
                        "UserCount": 725,
                        "RightCount": 452,
                        "FavCount": 11,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 6
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002483,
                    "ChildTableID": 43000622
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 6
            },
            {
                "AllTestID": 43002484,
                "ChildTableID": 43000623,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002484,
                        "ChildTableID": 43000623,
                        "UserCount": 742,
                        "RightCount": 298,
                        "FavCount": 20,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 3
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002484,
                    "ChildTableID": 43000623
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 3
            },
            {
                "AllTestID": 43002484,
                "ChildTableID": 43000624,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002484,
                        "ChildTableID": 43000624,
                        "UserCount": 732,
                        "RightCount": 296,
                        "FavCount": 18,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 2
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002484,
                    "ChildTableID": 43000624
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 2
            }
        ],
        "info": [],
        "encoded": 1,
        "examHistoryID": 0,
        "yimoinfo": [],
        "UserTime": 0
    },
    "status": 200
}